The invention relates to chemistry, namely to the synthesis of a coordinative compound from the class of thiosemicarbazonates of transition metals and can be applied in medicine for prophylaxis and treatment of myeloid leukemia. Summary of the invention consists in that as inhibitor of human myeloid leukemia is proposed bis(2-hydroxy-8-phenyl-tricyclo/7.3.1.0.2,7/-tridecane-13-on-thiosemicarbazonato)copper of formula:
展开▼